Creative Planning

Position in CORT — Corcept Therapeutics Inc

CIK 1540235 OVERLAND PARK, KS

Position in CORT

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$7,156,071

+$5,673,107 QoQ

Shares Held

82,301

+123.7% QoQ

Ownership

0.076%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#86

of 423 holders

Holding Since

Mar 2023

12 quarters on record

Voting authority Sole 1% Shared 0% None 99%

Healthcare · as of Jun 30, 2026

Creative Planning holds $452,608,635 across 219 Biotechnology names. CORT ranks #16 (1.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	127,672	$63,418,511
2	REGN	Regeneron Pharmaceuticals, Inc.	36,949	$23,039,178
3	EXEL	Exelixis, Inc.	270,292	$14,706,586
4	INCY	Incyte Corp	110,664	$12,544,870
5	CYTK	Cytokinetics Inc	141,939	$12,091,783
6	RVMD	Revolution Medicines, Inc.	64,120	$12,008,393
7	ARGX	Argenx SE	12,744	$11,823,500
8	BMRN	Biomarin Pharmaceutical Inc	153,161	$8,763,872

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$7,156,071	82,301	+123.7%	Shares	Defined	2026-08-13
2026-03-31	$1,482,964	36,789	+13.4%	Shares	Sole	2026-05-12
2025-12-31	$1,129,399	32,454	-0.3%	Shares	Sole	2026-02-17
2025-09-30	$2,704,482	32,541	+2.2%	Shares	Defined	2025-11-14
2025-06-30	$2,336,175	31,828	+49.4%	Shares	Defined	2025-08-08
2025-03-31	$2,433,799	21,308	+36.8%	Shares	Sole	2025-05-15
2024-12-31	$784,773	15,574	+24.9%	Shares	Defined	2025-02-14
2024-09-30	$576,972	12,467	+7.2%	Shares	Defined	2024-10-11
2024-06-30	$377,728	11,626	+18.2%	Shares	Sole	2024-08-15
2024-03-31	$247,668	9,832	+39.7%	Shares	Sole	2024-05-13
2023-12-31	$228,659	7,040	-24.2%	Shares	Sole	2024-02-14
2023-03-31	$201,221	9,290	—	Shares	Sole	2023-05-15
No filing history on record for this holder in this stock.